Health Canada Confirms BioPharma Services Inc. in Full Compliance Following Successful QI Inspection
BioPharma Services Inc., a leading global Contract Research Organization (CRO), is pleased to announce the successful completion of a comprehensive Quality Inspection (QI) by Health Canada at its clinical research facility. The inspection was conducted in accordance with the Good Clinical Practices (GCP) Guideline – ICH E6 and Health Canada’s Food and Drug Regulations, Part C – Division 5.